Cloud security is changing. Attackers are no longer just breaking down the door; they are finding unlocked windows in your configurations, your identities, and your code. Standard security tools often miss these threats because they look like normal activity. To stop them, you need to see...
Three security vulnerabilities have been disclosed in the Peripheral Component Interconnect Express (PCIe) Integrity and Data Encryption (IDE) protocol specification that could expose a local attacker to serious risks. The flaws impact PCIe Base Specification Revision 5.0 and onwards in the...
Amsbio (Oxford, UK) reports that its iMatrix-511 recombinant laminin product has been cited in a recent paper from researchers at the Stanford University School of Medicine (CA, USA) as a pivotal tool for stem cell culture and blastoid formation. This groundbreaking study describes how human...
Original story from the Terasaki Institute for Biomedical Innovation (CA, USA). New organ-on-a-chip platform allows the testing of cancer vaccine efficacy in aging populations, which may help guide the development of next-generation immunotherapies designed to meet the needs of older patients....
The holiday season is upon us! Looking for the perfect present for the scientist – or, if you’re lucky, scientists – in your life? We’ve got you covered. Ends of the Earth: Journeys to the Polar Regions in Search of Life, the Cosmos, and our Future by Neil Shubin In case it isn’t...
In a step forward for bispecific antibodies, study results presented at ASH suggest a Tecvayli-based combination could have curative potential early in a patient’s disease course.
Continue reading →
Ianalumab, which has already succeeded in testing against Sjogren’s syndrome, proved impactful in a condition that causes low platelet counts.
Continue reading →
A potentially $2 billion deal with a subsidiary of Shanghai-based Fosun Pharma gives Pfizer a new chance at an oral weight loss medication, an area where its internal research has struggled.
Continue reading →